Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Gimme Care vs RestorLife Med

Two GLP-1 deals, scored on the same six factors. Gimme Care lands a Value Score of 91, RestorLife Med a 73. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Gimme Care

#5 · Grade A · Best Value

Est. first month

$130/mo

Save ~90% vs brand-name
Get this deal Full Gimme Care review →
VS

RestorLife Med

#181 · Grade C+ · Watch List

Est. first month

From $299/mo (compounded)

Save ~78% vs brand-name
Get this deal Full RestorLife Med review →

The verdict

Better value: Gimme Care

Gimme Care takes it on Value Score, 91 to 73 an est. $130/mo first month, with no teaser step-up baked in. RestorLife Med isn't out of it: Shoppers who want gLP-1 weight care from a named board-certified physician, with microdosing and strong clinical support.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealGimme CareRestorLife Med
Value Score91 (A)73 (C+)
Est. first month$130/moFrom $299/mo (compounded)
Save vs brand-name~90%~78%
Semaglutide$130/moFrom $299/mo (compounded)
Tirzepatide$163/moFrom $399/mo (compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

93
Lowest Real Price
52
Gimme Care: 93. RestorLife Med: 52.
88
No Teaser-Rate Bait
62
Gimme Care: 88. RestorLife Med: 62.
98
Nationwide Availability
96
Gimme Care: 98. RestorLife Med: 96.
92
Both Molecules
92
Gimme Care: 92. RestorLife Med: 92.
84
Easy Cancellation
95
Gimme Care: 84. RestorLife Med: 95.
82
Reputation
92
Gimme Care: 82. RestorLife Med: 92.

Gimme Care

Genuinely cheap on both molecules ($130 / $163) with a LegitScript-certified pharmacy and all-50-state reach.

Why it's a deal

  • Low flat price on both molecules ($130 sema / $163 tirz)
  • LegitScript-certified pharmacy
  • Available in all 50 states

The fine print

  • No brand-name option — compounded only
  • No oral/sublingual form

RestorLife Med

RestorLife Med is a physician-guided GLP-1 telehealth practice (founder Dr.

Why it's a deal

  • Verifiable LegitScript certification (seal ID 50400451) plus a named board-certified physician (Dr. Michael Wasef, MD) licensed in all 50 states
  • Full GLP-1 lineup: compounded semaglutide and tirzepatide, plus gentler microdose entry options
  • Generous support — unlimited care-team messaging, monthly check-ins, dosage adjustments, and 1 free blood test per quarter on the GLP-1 protocols
  • Available in all 50 states with free priority shipping, discreet packaging, and roughly 48-hour delivery
  • Transparent multi-month pricing with 50% off your first month; semaglutide protocols are compounded with B12

The fine print

  • Compounded medications are not FDA-approved as finished products (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Ongoing pricing is mid-range ($299/mo semaglutide, $399/mo tirzepatide) after the discounted first month
  • The specific partner compounding pharmacy is not named
  • Also markets hormone therapy and anti-aging peptides, not GLP-1 exclusively
Get the Gimme Care deal Get the RestorLife Med deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Gimme Care is ranked on the Gimme Care alternatives board, and the same list for the other side is on alternatives to RestorLife Med.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.